Methodology

All entries for: Opna Bio LLC

December 19, 2025

Opna Bio LLC

Orphan Drug Designation

FDA orphan drug designation: treatment of myelofibrosis

Disease Area: Rare Diseases
Source
Source
Scroll to Top